CoChat

Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

Dangouloff, Tamara, Vrščaj, Eva, Servais, Laurent, Osredkar, Damjan, Adoukonou, Thierry, Aryani, Omid, Barisic, Nina, Bashiri, Fahad, Bastaki, Laila, Benitto, Afaf, Omran, Tawfeg Ben, Bernert, Guenther, Bertini, Enrico, Borde, Patricia, Born, Peter, Boustani, Rose-Mary, Butoianu, Nina, Castiglioni, Claudia, Catibusic, Feriha, Chan, Sophelia, Chien, Yin Hsiu, Christodoulou, Kyproula, Dejsuphong, Donniphat, Farrar, Michelle, Filip, Duma, Goemans, Nathalie, Guinhouya, Kokou, Haberlova, Jana, Hadzsiev, Kinga, Hovhannesyan, Kristine, Isohanni, Pirjo, Radovic, Nelica Ivanovic, Jacquier, David, Jalloh, Alusine, Jedrzejowska, Maria, Kandawasvika, Gwen, Kaputu, Celestin, Kawatu, Nfwama, Kernohan, Kristin, Kirschner, Jan, Klink, Barbara, Kodsy, Sherry, Kouame-Assouan, Ange-Eric, Kravljanac, Ruzica, Kreile, Madara, Litvinenko, Ivan, McMillan, Hugh, Mesa, Sandra, Mohamed, Inaam, Kanzoska, Liljana Muaremoska, Nevo, Yoram, Nguefack, Seraphin, Nkole, Kafula, O'Grady, Gina, O'Rourke, Declan, Oskoui, Maryam, Piazzon, Flavia, Poddighe, Dimitri, Prasauskiene, Audrone, Prieto, Juan, Rasmussen, Magnhild, Razafindrasata, Santara, Saha, Narayan, Saito, Kayoko, Sakadi, Foksouna, Sangare, Modibo, Schroth, Mary, Shalkevich, Leanid, Shatillo, Andriy, Suthar, Renu, Szabo, Lena, Tatishvili, Nana, Tazir, Meriem, Tizzano, Eduardo, Topaloglu, Haluk, Tulinius, Mar, van der Pol, Ludo, Vazquez, Gabriel, Vlodavets, Dimitry, Wanigasinghe, Jithangi, Wilmshurst, Jo, Xiong, Hui, Zafeiriou, Dimitrios, Zamba, Eleni · 2021 · Neuromuscular Disorders
Cited by 176

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Spinal muscular atrophy (SMA) is a rare and devastating disease. New disease-modifying treatments have recently been approved and early treatment has been related to a better outcome. In this context, several newborn screening (NBS) programs have been implemented. The aim of the study was to obtain a global overview on the current situation and perspectives on SMA NBS. We conducted a survey and contacted experts from 152 countries, from which we gathered 87 responses. We identified 9 SMA NBS programs that have so far detected 288 newborns with SMA out of 3,674,277 newborns screened. Funding, screening methods, organisation, and consent process were variable between SMA NBS programs. Many respondents pointed the lack of cost/benefit data as a major obstacle to SMA NBS implementation. In the next four years, our data suggest a 24% coverage of newborns from countries where a disease-modifying drug is available and 8,5% coverage in countries with no diseases-modifying drugs. The annual proportion of newborns to be screened in the coming years is expected to increase steadily. The experts expressed a strong need for the implementation of SMA NBS as means to improve care for patients with SMA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nmd.2021.03.007

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 176

Metadata

Authors
Dangouloff, T., Vrščaj, E., Servais, L., Osredkar, D., Adoukonou, T., Aryani, O., Barisic, N., Bashiri, F., Bastaki, L., Benitto, A., Omran, T. B., Bernert, G., Bertini, E., Borde, P., Born, P., Boustani, R.-M., Butoianu, N., Castiglioni, C., Catibusic, F., Chan, S., Chien, Y. H., Christodoulou, K., Dejsuphong, D., Farrar, M., Filip, D., Goemans, N., Guinhouya, K., Haberlova, J., Hadzsiev, K., Hovhannesyan, K., Isohanni, P., Radovic, N. I., Jacquier, D., Jalloh, A., Jedrzejowska, M., Kandawasvika, G., Kaputu, C., Kawatu, N., Kernohan, K., Kirschner, J., Klink, B., Kodsy, S., Kouame-Assouan, A.-E., Kravljanac, R., Kreile, M., Litvinenko, I., McMillan, H., Mesa, S., Mohamed, I., Kanzoska, L. M., Nevo, Y., Nguefack, S., Nkole, K., O'Grady, G., O'Rourke, D., Oskoui, M., Piazzon, F., Poddighe, D., Prasauskiene, A., Prieto, J., Rasmussen, M., Razafindrasata, S., Saha, N., Saito, K., Sakadi, F., Sangare, M., Schroth, M., Shalkevich, L., Shatillo, A., Suthar, R., Szabo, L., Tatishvili, N., Tazir, M., Tizzano, E., Topaloglu, H., Tulinius, M., van der Pol, L., Vazquez, G., Vlodavets, D., Wanigasinghe, J., Wilmshurst, J., Xiong, H., Zafeiriou, D., & Zamba, E.
Venue
Neuromuscular Disorders
Publisher
Elsevier BV
Published
2021-06
Volume
31
Issue
6
Pages
574-582
ISSN
0960-8966 (ISSN-L)
OpenAlex
W3143238609
Cited by
176
References
4
FWCI
14.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go. https://app.cochat.ai/papers/10.1016/j.nmd.2021.03.007
The paper
Dangouloff, T., Vrščaj, E., Servais, L., Osredkar, D., Adoukonou, T., Aryani, O., Barisic, N., Bashiri, F., Bastaki, L., Benitto, A., Omran, T. B., Bernert, G., Bertini, E., Borde, P., Born, P., Boustani, R.-M., Butoianu, N., Castiglioni, C., Catibusic, F., . . . Zamba, E. (2021). Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2021.03.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.